Collegium Pharmaceutical, Inc. COLL Segment — Corporate expenses

Similar metrics at other companies

PFGSegment Corporate — Segment Expenses

$184.4M+28.1%

ARH

ARHSReportable Segment — Corporate and administrative expenses

$56.75M+3.9%

BCCorporate Segment — Operating Expenses

$41.3M+22.2%

APO

APOGReportable Segment — Corporate and Other Expenses

$8.03M+0.2%

GXOReportable Segment — Corporate expenses

$16M+6.7%

RITMCorporate Category — Other segment expenses

$19.28M+96.8%

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s segment — corporate expenses?

Collegium Pharmaceutical, Inc. (COLL) reported segment — corporate expenses of $14.54M in Q1 2026.

How has Collegium Pharmaceutical, Inc.'s segment — corporate expenses changed year-over-year?

Collegium Pharmaceutical, Inc.'s segment — corporate expenses increased by 9.4% year-over-year, from $13.29M to $14.54M.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — corporate expenses?

Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — corporate expenses has grown at a 10.3% compound annual growth rate (CAGR), from $33.92M to $45.55M.

What does segment — corporate expenses mean?

Represents general and administrative costs incurred to support the overall business infrastructure, including executive management, legal, and human resources. This metric serves as a proxy for the company's overhead efficiency and operational scale.